ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 176 filers reported holding ZAI LAB LTD in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,829,992 | -43.7% | 1,268,202 | -35.8% | 0.00% | -40.0% |
| Q2 2023 | $54,737,716 | -73.2% | 1,973,953 | -67.9% | 0.01% | -44.4% |
| Q1 2023 | $204,487,070 | +51.7% | 6,148,138 | +40.0% | 0.01% | -30.8% |
| Q4 2022 | $134,794,705 | -16.3% | 4,390,707 | -6.7% | 0.01% | -23.5% |
| Q3 2022 | $160,981,000 | +36.3% | 4,707,041 | +38.2% | 0.02% | +41.7% |
| Q2 2022 | $118,115,000 | -41.1% | 3,405,854 | -25.3% | 0.01% | -25.0% |
| Q1 2022 | $200,410,000 | +4.0% | 4,556,829 | +48.6% | 0.02% | +14.3% |
| Q4 2021 | $192,761,000 | -51.6% | 3,067,017 | -18.8% | 0.01% | -56.2% |
| Q3 2021 | $398,245,000 | -49.0% | 3,778,772 | -14.4% | 0.03% | -47.5% |
| Q2 2021 | $781,536,000 | +73.4% | 4,415,705 | +30.7% | 0.06% | +60.5% |
| Q1 2021 | $450,707,000 | -32.4% | 3,377,850 | -31.4% | 0.04% | -35.6% |
| Q4 2020 | $666,786,000 | +28.3% | 4,926,748 | -21.1% | 0.06% | +11.3% |
| Q3 2020 | $519,517,000 | -10.6% | 6,246,438 | -11.7% | 0.05% | -17.2% |
| Q2 2020 | $581,080,000 | +52.7% | 7,075,122 | -4.3% | 0.06% | +20.8% |
| Q1 2020 | $380,575,000 | +35.8% | 7,392,647 | +9.7% | 0.05% | +71.0% |
| Q4 2019 | $280,214,000 | +28.6% | 6,737,550 | -0.0% | 0.03% | +19.2% |
| Q3 2019 | $217,960,000 | -7.2% | 6,737,551 | 0.0% | 0.03% | -3.7% |
| Q2 2019 | $234,938,000 | +36.4% | 6,737,551 | +15.5% | 0.03% | +28.6% |
| Q1 2019 | $172,208,000 | +27.6% | 5,835,589 | +0.4% | 0.02% | +16.7% |
| Q4 2018 | $134,921,000 | +19.2% | 5,810,578 | +0.0% | 0.02% | +38.5% |
| Q3 2018 | $113,190,000 | -3.7% | 5,810,571 | +14.9% | 0.01% | -7.1% |
| Q2 2018 | $117,539,000 | +13.1% | 5,055,427 | +3.9% | 0.01% | +16.7% |
| Q1 2018 | $103,904,000 | +14.4% | 4,866,682 | +13.8% | 0.01% | +9.1% |
| Q4 2017 | $90,791,000 | +21.5% | 4,276,524 | +54.5% | 0.01% | +22.2% |
| Q3 2017 | $74,750,000 | – | 2,768,485 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |